Preparation of Tumescent Anesthesia Solution
To prepare tumescent anesthesia from lidocaine hydrochloride 36mg/1.8mL cartridges with epinephrine 18mcg/1.8mL, you must dilute these dental cartridges into a large volume base solution to achieve safe concentrations of 0.05-0.1% lidocaine with 1:1,000 epinephrine, though using pre-made pharmaceutical-grade solutions is strongly preferred over dental cartridges for this application. 1
Standard Tumescent Solution Formula
The typical tumescent anesthesia preparation uses the following base formula per 1000 mL 2, 3:
- 1000 mL of 0.9% normal saline (base solution)
- Lidocaine to achieve 0.05-0.1% final concentration (500-1000 mg total)
- Epinephrine to achieve 1:1,000 concentration (1 mg total)
- Sodium bicarbonate 8-10 mEq (to reduce injection pain) 4
Converting Dental Cartridges to Tumescent Solution
Your dental cartridges contain 5:
- Lidocaine: 36 mg per 1.8 mL = 2% concentration
- Epinephrine: 18 mcg per 1.8 mL = 1:100,000 concentration
For 0.05% Lidocaine Solution (500 mg/1000 mL):
- Add approximately 14 cartridges (14 × 36 mg = 504 mg lidocaine) to 1000 mL saline
- This provides 252 mcg epinephrine (14 × 18 mcg), which exceeds the target 1:1,000 ratio
- Add additional epinephrine 1 mg/mL solution to reach 1 mg total if needed for optimal vasoconstriction 1
- Add 8-10 mEq sodium bicarbonate 4
For 0.1% Lidocaine Solution (1000 mg/1000 mL):
- Add approximately 28 cartridges (28 × 36 mg = 1008 mg lidocaine) to 1000 mL saline
- This provides 504 mcg epinephrine, still below optimal concentration
- Supplement with additional epinephrine to reach 1 mg total 1
Critical Safety Considerations
Maximum Safe Dosing
The maximum safe dose is 55 mg/kg of lidocaine with epinephrine for tumescent anesthesia in patients weighing 43.6-81.8 kg, which is substantially higher than standard infiltrative limits. 1 This contrasts with standard infiltrative anesthesia limits of 7 mg/kg with epinephrine 1, 6.
Volume Accuracy Warning
Be aware that 1-liter IV saline bags contain an average of 1051 mL (range 1033-1069 mL), not exactly 1000 mL, which reduces your final lidocaine concentration by 5-7%. 7 A prepared "0.05%" solution may actually be 0.045%, and a "0.1%" solution may be 0.086% 7.
Epinephrine Concentration Optimization
Epinephrine concentrations between 1:50,000 and 1:400,000 provide superior vasoconstriction compared to more dilute solutions; concentrations more dilute than 1:400,000 have delayed onset and shortened duration. 8 The standard 1:1,000 concentration is used primarily for safety in large-volume infiltration 2, 3.
Administration Technique
Injection Protocol
- Warm the solution to 40°C before administration to significantly reduce patient discomfort 1
- Use slow infiltration rate to minimize pain during administration 1
- Inject with a 2-mm cannula into the suprafascial plane of subcutaneous adipose tissue 4
- Infiltrate 2-3 mL per dermatome for regional procedures 1
Safety Monitoring
Aspirate before each injection to avoid intravascular administration, use incremental injections, and continuously monitor for early signs of local anesthetic systemic toxicity (LAST). 1 Early signs include circumoral numbness, facial tingling, metallic taste, dizziness, or euphoria 6.
Pharmacokinetic Considerations
Peak plasma lidocaine levels occur 4-12 hours after tumescent infiltration when epinephrine is used, representing a depot-like absorption pattern that allows safe use of higher total doses. 2, 9 This delayed absorption permits hepatic clearance to maintain safe blood levels 2.
Important Caveats
Practical Limitations
Using dental cartridges for tumescent preparation is technically feasible but impractical and not standard practice. 10 Standard tumescent solutions are prepared from 50 mL vials of 1% lidocaine (which actually contain 54 mL on average) 7, not dental cartridges.
Contraindications for Epinephrine
Do not inject into digits, hands, feet, or buttocks due to risk of tissue necrosis and gas gangrene. 11 For digital blocks, if epinephrine is used, concentrations of 1:80,000 to 1:1,000 appear safe in healthy adults 12.
Patient Selection
Exercise extreme caution in patients with cardiac disease, hepatic impairment, or those taking medications affecting hepatic drug clearance, as these conditions impair lidocaine metabolism. 2, 9 Patients with significant cardiopulmonary risk factors should not undergo tumescent anesthesia in outpatient settings 9.